As of Feb 16
| +1.15 / +4.90%|
The 4 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +21.85% increase from the last price of 24.62.
The current consensus among 4 polled investment analysts is to Hold stock in NxStage Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.